Guardian Pharmacy Services (GRDN) Q3 FY2026 earnings: revenue $371 million, down 1.7% on the year
Guardian Pharmacy Services, Inc. (GRDN) reported revenue of $371 million for Q3 FY2026, the quarter ended 30 September 2026, down 1.7% on the same quarter a year earlier. Net income was $19 million, up 90.3% on the year, and diluted earnings per share $0.29. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.
Revenue
$371 million
-1.7% on the year · +5.5% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
6.8%
4.3% a year earlier
Q4 FY2024Q3 FY2026
Net income
$19 million
+90.3% on the year · -14.6% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.29
+93.3% on the year · -14.7% on the quarter
Q4 FY2024Q3 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 2 raised.
Revenue down 2% year-over-year: Revenue was $371.1 million, against $377.4 million a year earlier, including IRA-related pricing decreases. Nine-month revenue was $1,059.4 million, against $1,051.1 million.
Net income nearly doubled: Net income was $19.1 million, against $9.6 million. Operating income was $25.1 million, against $16.4 million, with higher gross profit.
Adjusted EBITDA up 24%: Adjusted EBITDA was $33.9 million, up 24% year-over-year. Nine-month Adjusted EBITDA was $93.3 million, against $75.7 million a year earlier.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
43.4
30.0
28.2
+44.4%
+54.0%
Capital expenditure
n/a
n/a
4.0
Free cash flow
n/a
n/a
24.2
Free cash flow margin
n/a
n/a
6.4%
Cash from investing
-10.9
-4.3
-9.0
Cash from financing
-2.6
-0.8
-1.5
Depreciation and amortisation
5.9
5.8
5.8
+2.1%
+1.6%
Share-based compensation
2.7
2.9
4.4
-6.7%
-37.2%
Buybacks
n/a
n/a
0.0
Diluted shares, weighted
64m
n/a
63m
+0.8%
Shares outstanding at period end
63m
63m
63m
+0.0%
+0.1%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
280
258
195
+8.6%
+43.1%
Debt
0.0
0.0
0.0
Operating lease liabilities
28.0
27.9
27.4
+0.4%
+2.2%
Other liabilities
184
158
167
+16.5%
+10.1%
Total liabilities and equity
492
444
390
+10.9%
+26.1%
Fixed assets
57.4
56.5
56.1
+1.6%
+2.3%
Goodwill
82.0
79.7
79.6
+2.8%
+3.0%
Intangible assets
20.8
16.6
18.9
+25.4%
+10.2%
Cash and equivalents
120
89.8
36.5
+33.2%
+227.9%
Receivables
108
104
106
+3.8%
+1.4%
Inventory
57.1
50.4
47.9
+13.1%
+19.2%
Other assets
47.2
46.7
44.9
+1.1%
+5.1%
Total assets
492
444
390
+10.9%
+26.1%
Questions
What was Guardian Pharmacy Services' revenue in Q3 FY2026?
Guardian Pharmacy Services (GRDN) reported revenue of $371 million for Q3 FY2026, the quarter ended 30 September 2026, down 1.7% on the same quarter a year earlier.
How much did Guardian Pharmacy Services earn in Q3 FY2026?
Net income for Q3 FY2026 was $19 million, up 90.3% on the year, and diluted earnings per share $0.29.
When did Guardian Pharmacy Services report Q3 FY2026 results?
Guardian Pharmacy Services filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.